Gastrointestinal issues are the most common side effects of Ozempic, with approximately 20% of patients experiencing nausea
However, its use can sometimes come with side effects, the most common being nausea
Andrew Huberman: And now in humans as well
As a class, however, these agents work similarly where they mimic the structure of GLP-1 in vivo , and thus, can bind the GLP-1R, but are not subject to degradation by DPP-4
Cagrilintide in the Broader Peptide Landscape The metabolic peptide field has expanded dramatically, with various compounds targeting different aspects of metabolism: GLP-1 agonists (semaglutide, liraglutide) Single incretin pathway Dual agonists (tirzepatide) GIP + GLP-1 pathways Amylin analogues (cagrilintide) Amylin pathway Triple agonists (retatrutide) GIP + GLP-1 + Glucagon Metabolic modulators (5-Amino-1MQ) NNMT inhibition Each class offers unique mechanisms and potential applications in metabolic research